Alliance Pharma (GB:APH) has released an update.
Alliance Pharma PLC has notified the market of a significant change in share ownership, with Van Lanschot Kempen Investment Management NV acquiring a new total voting rights percentage of 8.9111% after a recent transaction. The notification follows the threshold being crossed on May 31, 2024, with Alliance Pharma being informed on June 4, 2024. This change represents a decrease from the previous notification where Van Lanschot Kempen held 9.90029% total voting rights in the company.
For further insights into GB:APH stock, check out TipRanks’ Stock Analysis page.
